M S Urdea

3.3k total citations · 1 hit paper
35 papers, 2.7k citations indexed

About

M S Urdea is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, M S Urdea has authored 35 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Epidemiology and 11 papers in Hepatology. Recurrent topics in M S Urdea's work include Hepatitis C virus research (11 papers), Hepatitis B Virus Studies (7 papers) and HIV Research and Treatment (6 papers). M S Urdea is often cited by papers focused on Hepatitis C virus research (11 papers), Hepatitis B Virus Studies (7 papers) and HIV Research and Treatment (6 papers). M S Urdea collaborates with scholars based in United States, United Kingdom and Switzerland. M S Urdea's co-authors include Ray Sánchez-Pescador, James P. Merryweather, Pablo Valenzuela, Ulrike Heberlein, Daniel G. Coit, Guy T. Mullenbach, V M Watt, Peter Simmonds, C. James Ingles and William J. Rutter and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nucleic Acids Research.

In The Last Decade

M S Urdea

35 papers receiving 2.5k citations

Hit Papers

Characterization of the terminal regions of hepatitis C v... 1991 2026 2002 2014 1991 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M S Urdea United States 23 1.1k 991 984 480 358 35 2.7k
H. Van Heuverswyn Belgium 18 963 0.9× 629 0.6× 983 1.0× 278 0.6× 96 0.3× 34 2.7k
Udayan Chatterji United States 28 789 0.7× 642 0.6× 855 0.9× 372 0.8× 769 2.1× 51 2.0k
Robert T. Sarisky United States 33 1.5k 1.4× 533 0.5× 645 0.7× 561 1.2× 259 0.7× 65 3.0k
Eberhard Pfaff Germany 34 1.4k 1.3× 1.0k 1.1× 1.5k 1.5× 519 1.1× 230 0.6× 80 3.7k
Michael Bobardt United States 28 823 0.8× 719 0.7× 1.2k 1.2× 551 1.1× 910 2.5× 65 2.7k
Reinhard Glück Switzerland 32 1.3k 1.2× 305 0.3× 926 0.9× 666 1.4× 178 0.5× 81 2.8k
Yu‐Mei Wen China 25 917 0.8× 689 0.7× 741 0.8× 516 1.1× 102 0.3× 64 2.0k
Donald R. O’Boyle United States 25 1.8k 1.6× 1.4k 1.4× 341 0.3× 722 1.5× 259 0.7× 37 2.4k
Shigeharu Ueda Japan 30 1.2k 1.1× 210 0.2× 837 0.9× 607 1.3× 340 0.9× 137 2.9k
Sandra Nuti Italy 27 1.1k 1.0× 865 0.9× 556 0.6× 325 0.7× 183 0.5× 54 3.2k

Countries citing papers authored by M S Urdea

Since Specialization
Citations

This map shows the geographic impact of M S Urdea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M S Urdea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M S Urdea more than expected).

Fields of papers citing papers by M S Urdea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M S Urdea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M S Urdea. The network helps show where M S Urdea may publish in the future.

Co-authorship network of co-authors of M S Urdea

This figure shows the co-authorship network connecting the top 25 collaborators of M S Urdea. A scholar is included among the top collaborators of M S Urdea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M S Urdea. M S Urdea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McKenna, Michael P., Valeriya Lyssenko, Michael W. Rowe, et al.. (2009). The diabetes risk score outperforms fasting plasma glucose and glucose tolerance tests: combined results from the Inter99 and Botnia Studies. Lund University Publications (Lund University). 1 indexed citations
2.
Sullivan, SD, et al.. (2008). OM4 LONG-TERM COST-EFFECTIVENESS OF A DIABETES RISK SCORE IN CLINICAL PRACTICE. Value in Health. 11(3). A21–A21. 1 indexed citations
3.
Smith, D. B., Fordyce A. Davidson, P.L. Yap, et al.. (1996). Levels of Hepatitis C Virus in Blood Donors Infected with Different Viral Genotypes. The Journal of Infectious Diseases. 173(3). 727–730. 43 indexed citations
4.
Dailey, Peter J., Lennox J. Jeffers, David Bernstein, et al.. (1996). Hepatitis C virus RNA quantification in right and left lobes of the liver in patients with chronic hepatitis C. Journal of Viral Hepatitis. 3(5). 239–246. 33 indexed citations
5.
Ghany, Marc G., Tak Mao Chan, Ray Sánchez-Pescador, M S Urdea, & A.S. Lok. (1996). Correlation between serum HCV RNA and aminotransferase levels in patients with chronic HCV infection. Digestive Diseases and Sciences. 41(11). 2213–2218. 20 indexed citations
6.
Lau, Johnson Y.N., Peter Simmonds, & M S Urdea. (1995). Implications of variations of "conserved" regions of hepatitis C virus genome. The Lancet. 346(8972). 425–426. 87 indexed citations
7.
Smith, Donald B., J. Mellor, L M Jarvis, et al.. (1995). Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. Journal of General Virology. 76(7). 1749–1761. 199 indexed citations
8.
Holodniy, Mark, L Molé, David M. Margolis, et al.. (1995). Determination of human immunodeficiency virus RNA in plasma and cellular viral DNA genotypic zidovudine resistance and viral load during zidovudine-didanosine combination therapy. Journal of Virology. 69(6). 3510–3516. 34 indexed citations
9.
Bresters, Dorine, H. T. M. Cuypers, H. W. Reesink, et al.. (1994). Comparison of quantitative cDNA‐PCR with the branched DNA hybridization assay for monitoring plasma hepatitis C virus RNA levels in haemophilia patients participating in a controlled interferon trial. Journal of Medical Virology. 43(3). 262–268. 29 indexed citations
10.
Dewar, Robin, M Sarmiento, John A. Todd, et al.. (1994). Application OF Branched DNA Signal Amplification to Monitor Human Immunodeficiency Virus Type 1 Burden in Human Plasma. The Journal of Infectious Diseases. 170(5). 1172–1179. 156 indexed citations
11.
Todd, John A., Torange Yeghiazarian, B Hoo, et al.. (1994). Quantitation of human immunodeficiency virus plasma RNA by branched DNA and reverse transcription coupled polymerase chain reaction assay methods: A critical evaluation of accuracy and reproducibility. Serodiagnosis and Immunotherapy in Infectious Disease. 6(4). 233–239. 23 indexed citations
12.
Yatsuhashi, Hiroshi, O Inoue, Kaoru Inokuchi, et al.. (1993). Short and long‐term effects of interferon on serum markers of hepatitis C virus replication. Journal of Gastroenterology and Hepatology. 8(1). 1–6. 17 indexed citations
13.
Sherman, Kenneth E., Julia O’Brien, Shannon M. Harrison, et al.. (1993). Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections. Journal of Clinical Microbiology. 31(10). 2679–2682. 198 indexed citations
14.
Urdea, M S, et al.. (1990). A procedure for productive coupling of synthetic oligonucleotides to polystyrene microtiter wells for hybridization capture.. PubMed. 8(3). 276, 279–276, 279. 26 indexed citations
15.
Running, J A, et al.. (1989). A rapid chemiluminescent DNA hybridization assay for the detection of Chlamydia trachomatis. Journal of Bioluminescence and Chemiluminescence. 4(1). 357–366. 11 indexed citations
16.
Knott, Timothy J., S. Wallis, M. E. Robertson, et al.. (1985). The human apolipoprotein AII gene: structural organization and sites of expression. Nucleic Acids Research. 13(17). 6387–6398. 33 indexed citations
17.
Warner, B., et al.. (1984). Construction and Evaluation of an Instrument for the Automated Synthesis of Oligodeoxyribonucleotides. DNA. 3(5). 401–411. 37 indexed citations
18.
Brake, A J, James P. Merryweather, Daniel G. Coit, et al.. (1984). Alpha-factor-directed synthesis and secretion of mature foreign proteins in Saccharomyces cerevisiae.. Proceedings of the National Academy of Sciences. 81(15). 4642–4646. 393 indexed citations
19.
Urdea, M S, James P. Merryweather, Guy T. Mullenbach, et al.. (1983). Chemical synthesis of a gene for human epidermal growth factor urogastrone and its expression in yeast.. Proceedings of the National Academy of Sciences. 80(24). 7461–7465. 99 indexed citations
20.
Urdea, M S, Douglas J. Christie, Gerhard R. Munske, James A. Magnuson, & J. Ivan Legg. (1979). A Co(III) derivative of concanavalin A. Biochemical and Biophysical Research Communications. 91(3). 1045–1050. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026